Tiny balloon to relieve stuffy noses and headaches in the NHS –

A small balloon inflated into the nose will be thrown into the NHS to relieve sinus congestion and headaches.

Hospitals in the UK will have access to the gadget from next week, along with seven other new devices.

The Stryker XprESS handset is designed to inflate a balloon in a patient’s nose to treat chronic sinusitis when an infection has caused painful nasal congestion for more than three months.

Costs up to 1250 TL and helps to clean your nose by removing blockages.

The NHS has also ordered six more devices, including a steam device that can shrink an enlarged prostate, eliminating the need for lengthy and complex surgeries.

NHS England says the gadgets will save £57.5m a year compared to the cost of alternative procedures to healthcare.

There is also a portable drainage device to help patients get rid of heart and lung problems faster by aspirating fluid from the chest at different air pressures.

And people with sickle cell anemia will undergo an automatic blood cell replacement system.

NHS chief Amanda Pritchard praised the new devices at a board meeting today, saying that giving time to treat conditions will help doctors clear up the Covid backlog faster.

The Stryker XprESS handset is designed to inflate a balloon into a patient’s nose to treat chronic sinusitis, a condition in which an infection causes nasal congestion for more than three months.

He said: “The NHS has always been at the forefront of medical innovation, and while many of these devices are small, they will make a huge difference in the lives of tens of thousands of patients each year and save time for healthcare.

“From a tiny balloon that can go up the nose to relieve chest pain, to a steam blast that can shrink an enlarged prostate, these cutting-edge devices show how the NHS has embraced and launched the latest life-changing technology for patients nationwide at lightning speed.

“NHS staff are working hard to pay off Covid and technology can really help us on the road to recovery.”

Chronic sinusitis is swelling of the sinuses that lasts longer than 12 weeks.

It affects around 110,000 people in the UK and symptoms include pain, stuffy nose, decreased sense of smell and headache.

Patients make a “dental style” appointment to remove blockages with the device and can go home only two hours after they arrive at the hospital.

Meanwhile, Rezum’s 20-minute prostate steam treatment offers an alternative to expensive treatments for the 4 million men in the UK who suffer from enlarged glands each year.

John Ford, 69, lost bladder control due to prostate issues but found his condition improved after receiving steam treatment at Cambridge University Hospitals NHS Foundation Trust.

He said: ‘I’ve been antisocial – we’ve turned down a lot of invitations to go on something.

“I finally chose this procedure: it was minimally invasive, had no side effects, and was extremely fast.

“My quality of life used to be pretty low, but now it’s changed a lot.”

Rezum prostate steamer offers an alternative to expensive treatments for the four million men in the UK who suffer from enlarged glands each year

Thopaz portable chest drainage device helps chest and lung patients recover faster from their condition

Another tool that closes wounds while cutting during surgery – PLASMA – will also be available to those undergoing treatment for enlarged prostate.

Patients with sickle cell anemia can have the affected blood cells replaced by healthy ones by a donor with the Spectra Optia device.

Another tool that closes wounds during cutting during surgery – PLASMA – will also be offered to those undergoing treatment for enlarged prostate.

Urolift, which uses small implants to prevent the gland from blocking the flow of urine, will also be offered to patients with prostate enlargement.

GreenLight’s non-invasive laser treatment will offer these patients a fourth option.

Meanwhile, sickle cell patients can have their affected blood cells replaced by healthy ones by a donor with the Spectra Optia device.

The Thopaz portable drainage device will help chest and lung patients recover from their condition faster.

Matt Whitty, Director of Innovation, Research and Life Sciences at NHS England and NHS Recovery, said: “These seven medical technologies and four currently supported by policy are improving and saving lives.

“Through research and innovation, we can improve outcomes for patients by supporting patients and healthcare professionals to have equal access to innovation and transformative technologies.

“And by removing barriers to adoption, we will reduce health inequalities and improve equal access for all, particularly patients in disproportionately affected groups.”